PULL — Pure Extracts Technologies Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Pure Extracts Technologies, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
| 2017 December 31st | 2018 December 31st | 2019 December 31st | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | fxFinal | fxFinal | fxFinal | Final | Final | 
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.102 | 1.23 | 
| Cost of Revenue | |||||
| Gross Profit | — | — | — | -0.058 | 0.128 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.073 | 0.114 | 0.079 | 20.5 | 6.51 | 
| Operating Profit | -0.073 | -0.114 | -0.079 | -20.4 | -5.28 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.088 | -0.114 | -0.079 | -20.7 | -5.24 | 
| Net Income After Taxes | -0.088 | -0.114 | -0.079 | -20.7 | -5.24 | 
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 0.68 | -0.114 | -0.079 | -20.7 | -5.24 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.68 | -0.114 | -0.079 | -20.7 | -5.24 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.036 | -0.028 | -0.006 | -0.27 | -0.049 |